HEJDUK, Karel, Jakub ZÁVADA, Jiří VENCOVSKÝ, Karel PAVELKA and Jiří JARKOVSKÝ. ATTRA - clinical registry for monitoring effectiveness and safety of biological therapies for rheumatic diseases in Czech Republic: more than 10-years experience. In PAVELKA, Karel and Michal UHER. 9th Central European Congress of Rheumatology (CECR 2012). 2012.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name ATTRA - clinical registry for monitoring effectiveness and safety of biological therapies for rheumatic diseases in Czech Republic: more than 10-years experience
Name in Czech ATTRA - klinický registr pro monitorování efektivity a bezpečnosti biologické léčby revmatických onemocnění v České republice: více jak desetileté zkušenosti
Authors HEJDUK, Karel, Jakub ZÁVADA, Jiří VENCOVSKÝ, Karel PAVELKA and Jiří JARKOVSKÝ.
Edition 9th Central European Congress of Rheumatology (CECR 2012), 2012.
Other information
Type of outcome Presentations at conferences
Confidentiality degree is not subject to a state or trade secret
Keywords (in Czech) ATTRA, registr, revmatologie, biologická léčba
Keywords in English ATTRA, registry, rheumatology, biologic therapy
Tags International impact
Changed by Changed by: PhDr. Karel Hejduk, učo 142508. Changed: 11/2/2013 15:40.
Abstract
Arthritis - in all of its forms - is the leading cause of disability in developed countries. The clinical registry ATTRA was created in 2001 in the Czech Republic as a tool for continuous monitoring and assessment of clinical parametres in patients with rheumatic diseases (rheumatoid arthritis – RA, ankylosing spondylitis – AS, psoriatic arthritis – PSA, and juvenile idiopathic arthritis – JIA) who have been treated with biological therapies.
PrintDisplayed: 6/5/2024 10:13